DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Simon TG, Bonilla H, Yan P. et al.
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
Hepatology 2016;
64: 47-57
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.